Transformation Capital

Transformation Capital operates as a specialized growth equity firm targeting the intersection of healthcare technology and value-based care delivery models. The San Francisco-based firm has carved out a distinctive position in the competitive healthtech investment space by focusing exclusively on companies that demonstrate measurable impact on healthcare outcomes while building sustainable business models around alternative payment structures.

Since its 2017 founding, Transformation Capital has deployed capital across Series A and Series B+ rounds, with a particular emphasis on companies that have achieved product-market fit and are scaling their go-to-market operations. The firm's investment strategy centers on the thesis that healthcare's shift toward value-based reimbursement creates substantial opportunities for technology companies that can prove clinical efficacy and economic value.

This focus has led Transformation Capital to back companies spanning digital therapeutics, care management platforms, and clinical workflow optimization tools. The firm typically writes checks ranging from $10-30 million in initial investments, with significant reserves held for follow-on funding rounds. Transformation Capital's approach differentiates itself through deep healthcare industry expertise and a network of clinical advisors who help evaluate the medical validity and market potential of prospective investments.

The firm has established relationships with health systems, payers, and regulatory experts to support portfolio company growth and market access. With over $500 million in assets under management, Transformation Capital has positioned itself as a significant player in the healthtech venture capital ecosystem, though it remains smaller than generalist funds with healthcare exposure. The firm's concentrated sector focus allows for specialized due diligence capabilities and value-add services that larger, diversified funds may struggle to match.

Portfolio companies benefit from Transformation Capital's understanding of healthcare reimbursement mechanics, regulatory pathways, and the complex sales cycles inherent in selling to healthcare institutions. The firm's investment committee includes former healthcare executives and clinicians who bring operational expertise to investment decisions and portfolio support.